logo BDSP

Base documentaire

  1. Measles, mumps, and rubella antibodies in children 5-6 years after immunization : effect of vaccine type and age at vaccination.

    Article - En anglais

    The levels of antibody against measles, mumps, and rubella were determined at 5-6 years postimmunization in 468 children vaccinated with two different trivalent vaccines.

    The proportions of children without detectable antibody levels were 12 and 3.6% for measles (p<0.001), 14.9 and 7% for mumps (p=0.006), and 3.3 and 3.1% for rubella (p=0.88), respectively, in MMR II and Trivirix recipients.

    A higher proportion of those vaccinated at younger ages had undetectable or low levels of measles antibody.

    These data indicate that a large proportion of children vaccinated under routine conditions do not have detectable measles and mumps antibody.

    Mots-clés Pascal : Oreillons, Virose, Infection, Rougeole, Rubéole, Vaccination, Vaccin associé, Age, Sérologie, Réponse immune, Immunité humorale, Anticorps, Enfant, Homme, Québec, Canada, Amérique du Nord, Amérique

    Mots-clés Pascal anglais : Mumps, Viral disease, Infection, Measles, Rubella, Vaccination, Mixed vaccine, Age, Serology, Immune response, Humoral immunity, Antibody, Child, Human, Quebec, Canada, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0186586

    Code Inist : 002A05C07. Création : 199608.